MIKOBEAUTE INTERNATIONAL CO., LTD. AI Stock Analysis
MIKOBEAUTE INTERNATIONAL CO., LTD. (6574) AI Stock Analysis
MIKOBEAUTE INTERNATIONAL CO., LTD.
(TPEx:6574)
Mikobeaute scores moderately well, driven primarily by a solid financial profile: a very conservative balance sheet (0.15x debt-to-equity, equity funding ~81% of assets), a strong profit rebound with margins at multi-year highs, and improving ROE of 16.8%. A cheap 7.55x P/E and 3.09% dividend yield further support the case. The score is held back mainly by poor technicals — the stock trades below all key moving averages with negative MACD in a clear downtrend — and by fundamental caveats including a sharp gross margin decline, revenue still well below 2020 levels, and free cash flow falling ~75% on heavy capital spending. Sustained top-line recovery and a stabilising share price would be needed for a higher rating.
MIKOBEAUTE INTERNATIONAL CO., LTD. (6574) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 2.47B
- Dividend Yield
- 2.76%
- Average Volume (3M)
- 45.85K
- Price to Earnings (P/E)
- 8.3
- Beta (1Y)
- 0.26
- Revenue Growth
- 20.16%
- EPS Growth
- 136.85%
- Country
- TW
- Employees
- 543
- Sector
- General
- Sector Strength
- 55
- Industry
- Household & Personal Products
MIKOBEAUTE INTERNATIONAL CO., LTD. Business Overview & Revenue Model
Company Description
Mikobeaute International Co., Ltd. specializes in the distribution and direct sale of cosmetic products, reaching customers both in Taiwan and across international borders. The company markets its diverse range of beauty solutions under several brand...
MIKOBEAUTE INTERNATIONAL CO., LTD. Financial Statement Overview
Summary
Strong overall financial footing. Earnings inflected sharply higher, with revenue up ~6.5% to NT$621.7m, operating margin expanding to 28.3% from 19.4%, and net income up ~66% to NT$149.9m (24.1% net margin, a multi-year high). The balance sheet is a standout: equity funds ~81% of assets, debt-to-equity is just 0.15x, EBITDA covers total borrowings nearly 2x, and ROE improved to 16.8%. Offsetting this, gross margin compressed sharply to 57.1% from the prior 73–79% range, revenue remains well below 2020 levels, and free cash flow fell ~75% to NT$28.2m as capital spending consumed most of the NT$158.3m operating cash flow. Operating cash flow still fully covers net income (1.06x), supporting earnings quality.
Income Statement
72PositiveBalance Sheet
83Very PositiveCash Flow
62Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 734.05M | 621.68M | 583.69M | 620.02M | 681.25M | 648.27M |
| Gross Profit | 379.36M | 355.15M | 431.64M | 479.49M | 526.17M | 496.37M |
| EBITDA | 336.06M | 246.90M | 163.48M | 127.27M | 172.34M | 86.10M |
| Net Income | 291.14M | 149.91M | 90.26M | 46.52M | 68.05M | 13.82M |
Balance Sheet | ||||||
| Total Assets | 1.35B | 1.11B | 834.37M | 844.12M | 925.38M | 897.07M |
| Cash, Cash Equivalents and Short-Term Investments | 659.31M | 439.78M | 486.98M | 578.00M | 579.61M | 511.61M |
| Total Debt | 120.43M | 134.51M | 79.47M | 87.95M | 138.74M | 133.57M |
| Total Liabilities | 283.84M | 213.10M | 164.40M | 202.96M | 252.34M | 266.64M |
| Stockholders Equity | 1.07B | 892.46M | 669.97M | 641.16M | 666.04M | 624.80M |
Cash Flow | ||||||
| Free Cash Flow | 211.88M | 28.16M | 113.80M | 145.21M | 135.69M | 40.85M |
| Operating Cash Flow | 305.74M | 158.32M | 124.82M | 149.28M | 164.78M | 73.42M |
| Investing Cash Flow | -74.44M | 15.21M | -98.46M | -610.00K | -66.11M | 33.35M |
| Financing Cash Flow | -87.09M | -92.47M | -111.40M | -129.13M | -81.31M | -60.80M |
MIKOBEAUTE INTERNATIONAL CO., LTD. Peers Comparison
Overall Rating
TW:413868Neutral
TW:657466Neutral
TW:293757Neutral
TW:132541Neutral
TW:471437Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | TWD 2.15B | 15.50 | ― | 7.81% | -1.10% | -16.90% | |
| 66Neutral | TWD 2.39B | 8.31 | ― | 2.76% | 20.16% | 136.85% | |
| 57Neutral | TWD 2.06B | 10.51 | ― | 4.03% | 12.09% | 10.86% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 41Neutral | TWD 2.16B | -62.78 | ― | 1.19% | -21.19% | 47.07% | |
| 37Underperform | TWD 2.37B | -13.16 | ― | 1.77% | 74.42% | -247.01% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6574 | MIKOBEAUTE INTERNATIONAL CO., LTD. | 108.50 | 35.68 | 48.99% | |
| TW:1325 | Universal Incorporation | 25.30 | -5.95 | -19.04% | |
| TW:2937 | Gseven Co., Ltd. | 43.05 | 4.52 | 11.72% | |
| TW:2942 | Jing-Jan Retail Business Co., Ltd. | 34.80 | 6.06 | 21.11% | |
| TW:4138 | Dynamic Medical Technologies Inc. | 53.80 | -5.91 | -9.90% | |
| TW:4714 | U-Best Innovative Technology Co.,Ltd | 10.70 | -6.22 | -36.76% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
